We connect challenges and innovative ideas for generating new concepts around assays and biotechnology
Innovation is one of our fundamental strategic pillars.
We innovate at all levels: biomaterials, assays and manufacturing biotechnology processes.
Assay innovation includes design of immunoassay prototypes and proof-of-concept evaluation including relevant clinical data.
Innovation in biotechnology
We are working to incorporate new technologies to enhance our assays performance (sensitivity, specificity, stability) and improve our assay manufacturing processes (increase yield, scalability and the robustness of antigens and antibodies production).